1477 Results

People

  1. Motzer
    Motzer
  2. Hudis
    Hudis
  3. Aghajanian
    Aghajanian
  4. O'Reilly
    O'Reilly
  5. Kris
    Kris
  6. Scher
    Scher
  7. Panageas
    Panageas
  8. Saltz
    Saltz
  9. Schwartz
    Schwartz
  10. Kelsen
    Kelsen

Groups

  1. Department of Medicine (1039)
  2. Solid Tumor Oncology Division (784)
  3. Hematologic Malignancies, Division of (287)
  4. Survivorship Research (234)
  5. Center for Hematologic Malignancies (216)
  6. Genitourinary Oncology Service (208)
  7. Epidemiology and Biostatistics (194)
  8. Biostatistics Service (169)
  9. Gastrointestinal Oncology Service (160)
  10. Population Sciences Research Program (158)
  1. "fatigue"
Formats
  1. Journal Article (1402)
  2. Review (38)
  3. Research Letter (13)
  4. Editorial (10)
  5. Conference Paper (5)
  6. Guidelines (4)
  7. Correspondence (3)
  8. Book Section (2)
Groups
  1. Department of Medicine (1039)
  2. Solid Tumor Oncology Division (784)
  3. Hematologic Malignancies, Division of (287)
  4. Survivorship Research (234)
  5. Center for Hematologic Malignancies (216)
  6. Genitourinary Oncology Service (208)

More Groups

People
  1. Robert Motzer (85)
  2. Clifford Hudis (49)
  3. Carol Aghajanian (46)
  4. Eileen O'Reilly (46)
  5. Howard Scher (44)
  6. Mark Kris (44)

More People

Years
  1. 2025 (60)
  2. 2024 (132)
  3. 2023 (89)
  4. 2022 (46)
  5. 2021 (33)
  6. 2020 (85)

More Years

Publications
  1. Journal of Clinical Oncology (108)
  2. Clinical Cancer Research (82)
  3. Cancer (63)
  4. Lancet Oncology (50)
  5. Gynecologic Oncology (41)
  6. Annals of Oncology (37)

More Publications

Publishers
  1. Elsevier Inc. (244)
  2. Springer (133)
  3. American Society of Clinical Oncology (114)
  4. Elsevier Science, Inc. (108)
  5. Oxford University Press (101)
  6. American Association for Cancer Research (89)

More Publishers

Results (1477)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • First-in-human study of naporafenib (LXH254) with or without spartalizumab in adult patients with advanced solid tumors harboring MAPK signaling pathway alterations
    Journal Article

    Janku, F.; Kim, T. M.; Iyer, G.; Spreafico, A.; Elez, E.; de Jonge, M.; Yamamoto, N.; van der Wekken, A. J.; Ascierto, P. A.; Maur, M.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • An unusual cause of complete heart block
    Review

    O'Rourke, K.; Ma, T.; Bojko, K.; Chen, L.
    Critical Care Nursing Quarterly (2024)

    Fulltext@MSK | Save
  • Mental status changes in severe babesiosis
    Journal Article

    Navarro, M. J.; Karim, F.; Al-Ghanamah, R.; Maron, S. B.
    Annals of Internal Medicine Clinical Cases (2023)

    Fulltext@MSK | Save
  • Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: A randomized trial
    Journal Article

    Scott, J. M.; Lee, J.; Herndon, J. E.; Michalski, M. G.; Lee, C. P.; O'Brien, K. A.; Sasso, J. P.; Yu, A. F.; Rowed, K. A.; Bromberg, J. F.; more...
    European Heart Journal (2023)

    Fulltext@MSK | Save
  • Executive and social functioning in pediatric posterior fossa tumor survivors and healthy controls
    Journal Article

    Ramjan, S.; Levitch, C.; Sands, S.; Kim, S. Y.; Barnett, M.; Bledsoe, J.; Holland, A. A.
    Neuro-Oncology Practice (2023)

    Fulltext@MSK | Save
  • Acupuncture vs massage for pain in patients living with advanced cancer: The IMPACT randomized clinical trial
    Journal Article

    Epstein, A. S.; Liou, K. T.; Romero, S. A. D.; Baser, R. E.; Wong, G.; Xiao, H.; Mo, Z. L.; Walker, D.; MacLeod, J.; Li, Q.; more...
    JAMA Network Open (2023)

    Fulltext@MSK | Save
  • Very low-dose radiotherapy for extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue
    Journal Article

    Freret, M. E.; Tringale, K. R.; Boe, L.; Imber, B. S.; Joffe, E.; Yahalom, J.; Hajj, C.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Efficacy and safety of regorafenib in combination with immune checkpoint inhibitor therapy as second-line and third-line regimen for patients with advanced hepatocellular carcinoma: A retrospective study
    Journal Article

    Zhao, J.; Guo, Y.; Feng, T.; Rong, D.; Kong, X.; Huang, T.; Lopez-Lopez, V.; Yarmohammadi, H.; Sakamoto, Y.; Zhu, D.; more...
    Journal of Gastrointestinal Oncology (2023)

    Fulltext@MSK | Save
  • Innovative therapeutic approaches for patients with HER2-positive breast cancer
    Journal Article

    Taurelli Salimbeni, B.; Ferraro, E.; Boscolo Bielo, L.; Curigliano, G.
    Cancer Treatment and Research (2023)

    Fulltext@MSK | Save
  • Use of tamibarotene, a potent and selective RARĪ± agonist, in combination with azacitidine in patients with relapsed and refractory AML with RARA gene overexpression
    Journal Article

    Stein, E. M.; de Botton, S.; Cluzeau, T.; Pigneux, A.; Liesveld, J. L.; Cook, R. J.; Rousselot, P.; Rizzieri, D. A.; Braun, T.; Roboz, G. J.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save